{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T09:54:00Z","timestamp":1794390840813,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer US","isbn-type":[{"value":"9781441978400","type":"print"},{"value":"9781441978417","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-4419-7841-7_11","type":"book-chapter","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T11:30:14Z","timestamp":1309260614000},"page":"132-142","source":"Crossref","is-referenced-by-count":58,"title":["The Human Exosome and Disease"],"prefix":"10.1007","author":[{"given":"Raymond H. J.","family":"Staals","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ger J. M.","family":"Pruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1261\/rna.575107","volume":"13","author":"E.L. Dijk van","year":"2007","unstructured":"van Dijk EL, Schilders G, Pruijn GJ. Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways. RNA 2007; 13:1027\u20131035.","journal-title":"RNA"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1101\/gad.13.16.2148","volume":"13","author":"C. Allmang","year":"1999","unstructured":"Allmang C, Petfalski E, Podtelejnikov A et al. The yeast exosome and human PM-Scl are related complexes of 3\u2032\u21925\u2032 exonucleases. Genes Dev 1999; 13:2148\u20132158.","journal-title":"Genes Dev"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0092-8674(00)80432-8","volume":"91","author":"P. Mitchell","year":"1997","unstructured":"Mitchell P, Petfalski E, Shevchenko A et al. The exosome: a conserved eukaryotic RNA processing complex containing multiple 3\u2032\u21925\u2032 exoribonucleases. Cell 1997; 91:457\u2013466.","journal-title":"Cell"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1172\/JCI108616","volume":"59","author":"J.F. Wolfe","year":"1977","unstructured":"Wolfe JF, Adelstein E, Sharp GC. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 1977; 59:176\u2013178.","journal-title":"J Clin Invest"},{"key":"11_CR5","first-page":"658","volume":"11","author":"E.L. Treadwell","year":"1984","unstructured":"Treadwell EL, Alspaugh MA, Wolfe JF et al. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen. J Rheumatol 1984; 11:658\u2013662.","journal-title":"J Rheumatol"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF00915286","volume":"4","author":"M. Reichlin","year":"1984","unstructured":"Reichlin M, Maddison PJ, Targoff I et al. Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 1984; 4:40\u201344.","journal-title":"J Clin Immunol"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.137.12.3802","volume":"137","author":"G. Reimer","year":"1986","unstructured":"Reimer G, Scheer U, Peters JM et al. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis\/scleroderma overlap syndromes. J Immunol 1986; 137:3802\u20133808.","journal-title":"J Immunol"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.173.4.941","volume":"173","author":"F. Alderuccio","year":"1991","unstructured":"Alderuccio F, Chan EK, Tan EM. Molecular characterization of an autoantigen of PM-Scl in the polymyositis\/ scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 1991; 173:941\u2013952.","journal-title":"J Exp Med"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.176.4.973","volume":"176","author":"M. Bluthner","year":"1992","unstructured":"Bluthner M, Bautz FA. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J Exp Med 1992; 176:973\u2013980.","journal-title":"J Exp Med"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1172\/JCI115895","volume":"90","author":"Q. Ge","year":"1992","unstructured":"Ge Q, Frank MB, O\u2019Brien C et al. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest 1992; 90:559\u2013570.","journal-title":"J Clin Invest"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"30698","DOI":"10.1074\/jbc.M302488200","volume":"278","author":"R. Raijmakers","year":"2003","unstructured":"Raijmakers R, Vree Egberts WT, van Venrooij WJ et al. The association of the human PM\/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus. J Biol Chem 2003; 278:30698\u201330704.","journal-title":"J Biol Chem"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0022-2836(02)00947-6","volume":"323","author":"R. Raijmakers","year":"2002","unstructured":"Raijmakers R, Vree Egberts WT, van Venrooij WJ et al. Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring. J Mol Biol 2002; 323:653\u2013663.","journal-title":"J Mol Biol"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1074\/jbc.M007603200","volume":"276","author":"R. Brouwer","year":"2001","unstructured":"Brouwer R, Allmang C, Raijmakers R et al. Three novel components of the human exosome. J Biol Chem 2001; 276:6177\u20136184.","journal-title":"J Biol Chem"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0092-8674(01)00578-5","volume":"107","author":"C.Y. Chen","year":"2001","unstructured":"Chen CY, Gherzi R, Ong SE et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001; 107:451\u2013464.","journal-title":"Cell"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","volume":"24","author":"C.A. Muhlen von","year":"1995","unstructured":"von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24:323\u2013358.","journal-title":"Semin Arthritis Rheum"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/art.1780310409","volume":"31","author":"G. Reimer","year":"1988","unstructured":"Reimer G, Steen VD, Penning CA et al. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988; 31:525\u2013532.","journal-title":"Arthritis Rheum"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1101\/gr.2122004","volume":"14","author":"B. Lehner","year":"2004","unstructured":"Lehner B, Sanderson CM. A protein interaction framework for human mRNA degradation. Genome Res 2004; 14:1315\u20131323.","journal-title":"Genome Res"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1093\/nar\/gki982","volume":"33","author":"G. Schilders","year":"2005","unstructured":"Schilders G, Raijmakers R, Raats JM et al. MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation. Nucleic Acids Res 2005; 33:6795\u20136804.","journal-title":"Nucleic Acids Res"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/nar\/gkm082","volume":"35","author":"G. Schilders","year":"2007","unstructured":"Schilders G, van Dijk EL, Pruijn GJ. C1D and hMtr4p associate with the human exosome subunit PM\/ Scl-100 and are involved in prerRNA processing. Nucleic Acids Res 2007; 35:2564\u20132572.","journal-title":"Nucleic Acids Res"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/art.22710","volume":"56","author":"G. Schilders","year":"2007","unstructured":"Schilders G, Vree Egberts WT, Raijmakers R et al. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome. Arthritis Rheum 2007; 56:2449\u20132454.","journal-title":"Arthritis Rheum"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/ar389","volume":"4","author":"R. Brouwer","year":"2002","unstructured":"Brouwer R, Vree Egberts WT, Hengstman GJ et al. Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome. Arthritis Res 2002; 4:134\u2013138.","journal-title":"Arthritis Res"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/art.20056","volume":"50","author":"R. Raijmakers","year":"2004","unstructured":"Raijmakers R, Renz M, Wiemann C et al. PM-Scl-75 is the main autoantigen inpatients with the polymyositis\/ scleroderma overlap syndrome. Arthritis Rheum 2004; 50:565\u2013569.","journal-title":"Arthritis Rheum"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s001090050381","volume":"78","author":"M. Bluthner","year":"2000","unstructured":"Bluthner M, Mahler M, Muller DB et al. Identification of an alpha-helical epitope region on the PM\/ Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides. J Mol Med 2000; 78:47\u201354.","journal-title":"J Mol Med"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"R704","DOI":"10.1186\/ar1729","volume":"7","author":"M. Mahler","year":"2005","unstructured":"Mahler M, Raijmakers R, Dahnrich C et al. Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen. Arthritis Res Ther 2005; 7:R704\u2013R713.","journal-title":"Arthritis Res Ther"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/art.1780370619","volume":"37","author":"M. Kuwana","year":"1994","unstructured":"Kuwana M, Okano Y, Kaburaki J et al. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994; 37:902\u2013906.","journal-title":"Arthritis Rheum"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","volume":"40","author":"I. Hausmanowa-Petrusewicz","year":"1997","unstructured":"Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW et al. Clinical, s\u00e9rologic and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997; 40:1257\u20131266.","journal-title":"Arthritis Rheum"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar1862","volume":"8","author":"H. Chinoy","year":"2006","unstructured":"Chinoy H, Salway F, Fertig N et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 2006; 8:R13.","journal-title":"Arthritis Res Ther"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","volume":"85","author":"T.P. O\u2019Hanlon","year":"2006","unstructured":"O\u2019Hanlon TP, Carrick DM, Targoff IN et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1 and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006; 85:111\u2013127.","journal-title":"Medicine (Baltimore)"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/ar75","volume":"2","author":"P.J. Utz","year":"2000","unstructured":"Utz PJ, Gensler TJ, Anderson P. Death, autoantigen modifications and tolerance. Arthritis Res 2000; 2:101\u2013114.","journal-title":"Arthritis Res"},{"key":"11_CR30","first-page":"179","volume-title":"Cell Apoptosis Research Advances","author":"D. Hof","year":"2007","unstructured":"Hof D, Pruijn GJM, van Venrooij WJ et al. The role of cell death-specific modifications in breaking tolerance to self-antigens. In: Kettleworth CR, ed. Cell Apoptosis Research Advances. Hauppauge: Nova Science Publishers, 2007:179\u2013202."},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar2119","volume":"9","author":"G. Schilders","year":"2007","unstructured":"Schilders G, Raijmakers R, Malmegrim KC et al. Caspase-mediated cleavage of the exosome subunit PM\/ Scl-75 during apoptosis. Arthritis Res Ther 2007; 9:R12.","journal-title":"Arthritis Res Ther"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.190.6.815","volume":"190","author":"L. Casciola-Rosen","year":"1999","unstructured":"Casciola-Rosen L, Andrade F, Ulanet D et al. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190:815\u2013826.","journal-title":"J Exp Med"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","volume":"6","author":"M. Mahler","year":"2007","unstructured":"Mahler M, Raijmakers R. Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev 2007; 6:432\u2013437.","journal-title":"Autoimmun Rev"},{"key":"11_CR34","first-page":"296","volume":"60","author":"R. Gutierrez-Ramos","year":"2008","unstructured":"Gutierrez-Ramos R, Gonz Lez-Diaz V, Pacheco Tovar MG et al. A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies. Reumatismo 2008; 60:296\u2013300.","journal-title":"Reumatismo"},{"key":"11_CR35","first-page":"5517","volume":"62","author":"X.F. Yang","year":"2002","unstructured":"Yang XF, Wu CJ, Chen L et al. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. Cancer Res 2002; 62:5517\u20135522.","journal-title":"Cancer Res"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-131-3-199908030-00008","volume":"131","author":"S. Faderl","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z et al. Chronic myelogenous leukemia: biology and therapy. Ann Intern Med 1999; 131:207\u2013219.","journal-title":"Ann Intern Med"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"R.H. Collins","year":"1997","unstructured":"Collins RH, Jr., Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15:433\u2013444.","journal-title":"J Clin Oncol"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1172\/JCI10196","volume":"106","author":"C.J. Wu","year":"2000","unstructured":"Wu CJ, Yang XF, McLaughlin S et al. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest 2000; 106:705\u2013714.","journal-title":"J Clin Invest"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbrc.2006.06.093","volume":"347","author":"H. Zhou","year":"2006","unstructured":"Zhou H, Zhang D, Wang Y et al. Induction of CML28-specific cytotoxic T-cell responses using cotransfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector. Biochem Biophys Res Commun 2006; 347:200\u2013207.","journal-title":"Biochem Biophys Res Commun"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00262-007-0434-9","volume":"57","author":"L.H. Xie","year":"2008","unstructured":"Xie LH, Sin FW, Cheng SC et al. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene. Cancer Immunol Immunother 2008; 57:1029\u20131038.","journal-title":"Cancer Immunol Immunother"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/CJI.0b013e318176facc","volume":"31","author":"H. Mao","year":"2008","unstructured":"Mao H, Geng Z, Liu W et al. Selection of HLA-A2 restricted CML28 peptide by artificial antigen-presenting cells. J Immunother 2008; 31:487\u2013490.","journal-title":"J Immunother"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"10766","DOI":"10.1128\/MCB.24.24.10766-10776.2004","volume":"24","author":"F. Fang","year":"2004","unstructured":"Fang F, Hoskins J, Butler JS. 5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs. Mol Cell Biol 2004; 24:10766\u201310776.","journal-title":"Mol Cell Biol"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0092-8674(03)01035-3","volume":"116","author":"P.Y. Lum","year":"2004","unstructured":"Lum PY, Armour CD, Stepaniants SB et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004; 116:121\u2013137.","journal-title":"Cell"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2005.25.1","volume":"25","author":"K.S. Khabar","year":"2005","unstructured":"Khabar KS. The AU-rich transcriptome: more than interferons and cytokines and its role in disease. J Interferon Cytokine Res 2005; 25: 1\u201310.","journal-title":"J Interferon Cytokine Res"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1105\/tpc.109.066167","volume":"21","author":"L. Xi","year":"2009","unstructured":"Xi L, Moscou MJ, Meng Y et al. Transcript-based cloning of RRP46, a regulator of rRNA processing and R gene-independent cell death in barley-powdery mildew interactions. Plant Cell 2009; 21:3280\u20133295.","journal-title":"Plant Cell"}],"container-title":["Advances in Experimental Medicine and Biology","RNA Exosome"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-7841-7_11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T17:13:35Z","timestamp":1686158015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-7841-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781441978400","9781441978417"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-7841-7_11","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-7841-7","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}